RE:RE:🚀ProMIS’ PMN310 lead antibody therapeutic for ADCareful wording is good. I'd be fine if they just say we're partnering with $xyz on the development of PMN310 and have given them X number of shares at a price of Y per share. No need to say anything about the timeline or phase. We can read between the lines.
We have $7M from the Boston billionaires. We probably need a similar amount to get through Phase I. A large partner would certainly help w/ respect to confidence in PhII/III funding opportunities.